These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29373492)

  • 1. Do Neuroendocrine Peptides and Their Receptors Qualify as Novel Therapeutic Targets in Osteoarthritis?
    Grässel S; Muschter D
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29373492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.
    Böhm M; Grässel S
    Endocr Rev; 2012 Aug; 33(4):623-51. PubMed ID: 22736674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.
    Maduna T; Lelievre V
    J Neurosci Res; 2016 Dec; 94(12):1472-1487. PubMed ID: 27717098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Nerve Fibers and Their Neurotransmitters in Osteoarthritis Pathology.
    Grässel S; Muschter D
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.
    Pintér E; Pozsgai G; Hajna Z; Helyes Z; Szolcsányi J
    Br J Clin Pharmacol; 2014 Jan; 77(1):5-20. PubMed ID: 23432438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.
    Mounien L; Do Rego JC; Bizet P; Boutelet I; Gourcerol G; Fournier A; Brabet P; Costentin J; Vaudry H; Jégou S
    Neuropsychopharmacology; 2009 Jan; 34(2):424-35. PubMed ID: 18536705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components.
    Grässel S; Opolka A; Anders S; Straub RH; Grifka J; Luger TA; Böhm M
    Arthritis Rheum; 2009 Oct; 60(10):3017-27. PubMed ID: 19790046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide regulation of AtT-20/D16v corticotrope cell proopiomelanocortin expression and secretion.
    Braas KM; Brandenburg CA; May V
    Endocrinology; 1994 Jan; 134(1):186-95. PubMed ID: 8275932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.
    Ganea D; Rodriguez R; Delgado M
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):127-42. PubMed ID: 12887096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PACAP and VIP signaling in chondrogenesis and osteogenesis.
    Juhász T; Helgadottir SL; Tamás A; Reglődi D; Zákány R
    Peptides; 2015 Apr; 66():51-7. PubMed ID: 25701761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of neuropeptides/hormones on Langerhans cells.
    Torii H; Tamaki K; Granstein RD
    J Dermatol Sci; 1998 May; 20(1):21-8. PubMed ID: 10342745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.